...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Histamine H3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats.
【24h】

Histamine H3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats.

机译:组胺H3受体介导的大鼠交感诱发的散瞳的抑制。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study was designed to determine if the histamine H3 receptor agonist R-alpha-methylhistamine would play a role in modulation of sympathetically evoked mydriasis in anesthetized rats, and if so, to ascertain the specific receptor subtype(s) involved. Reproducible frequency-response curves of pupillary dilation were generated by stimulation of the cervical preganglionic sympathetic nerve (1-32 Hz). Systemic administration of R-alpha-methylhistamine (0.3-3.0 mg kg(-1)) produced a dose-related inhibition of the evoked mydriasis. The greatest inhibition was seen at lower frequency levels, with about 43% depression observed at 2 Hz. The specific histamine H3 receptor antagonist, clobenpropit (3.0 mg kg(-1), i.v.), blocked the inhibitory effect of R-alpha-methylhistamine, whereas neither the histamine H2 receptor antagonist, cimetidine (5.0 mg kg(-1), i.v.), nor the histamine H1 receptor antagonist, chlorpheniramine (0.5 mg kg(-1), i.v.), was effective. The histamine H2 receptor agonist, dimaprit (10 mg kg(-1), i.v.), was also without effect on the evoked mydriasis. R-alpha-methylhistamine (3.0 mg kg(-1)) did not inhibit phenylephrine-induced mydriasis. These results support the conclusion that R-alpha-methylhistamine produces inhibition of sympathetically evoked mydriasis via histamine H3 receptor stimulation, presumably by an action on presynaptic histamine H3 receptors.
机译:这项研究旨在确定组胺H3受体激动剂R-α-甲基组胺是否会在麻醉大鼠的交感诱发的散瞳的调节中发挥作用,如果是,则确定所涉及的特定受体亚型。通过刺激颈神经节前交感神经(1-32 Hz),产生可再现的瞳孔扩张频率响应曲线。 R-α-甲基组胺(0.3-3.0 mg kg(-1))的全身给药对诱发的瞳孔散大产生剂量相关的抑制作用。在较低的频率水平上观察到最大的抑制,在2 Hz处观察到约43%的抑制。特定的组胺H3受体拮抗剂clobenpropit(3.0 mg kg(-1),iv)阻断了R-α-甲基组胺的抑制作用,而组胺H2受体拮抗剂cimetidine(5.0 mg kg(-1),iv ),组胺H1受体拮抗剂扑尔敏(0.5 mg kg(-1),iv)也不有效。组胺H2受体激动剂dimaprit(10 mg kg(-1),i.v.)对诱发的瞳孔散大也没有影响。 R-α-甲基组胺(3.0 mg kg(-1))不会抑制去氧肾上腺素引起的瞳孔散大。这些结果支持以下结论:R-α-甲基组胺可能通过对组胺H3受体的刺激而通过组胺H3受体的刺激产生对交感诱发的散瞳的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号